IMI Information Day
30-04-08
A major information dissemination event was held in Brussels on Wednesday 30 April to allow all key stakeholders find out more about the Innovative Medicines Initiative. The one-day event provided potential stakeholders with full details of the scientific priorities of the IMI. Participants got initial guidance on the application procedures for consortia considering making applications for funding under the first IMI Call for proposals. The meeting provided an initial networking opportunity for those in the public sector, the European pharmaceutical industry, the SME biopharmaceutical community and interested patient group representatives with an interest in supporting the IMI’s research programme.
First Governing Board meeting
03-03-08
The IMI Governing Board, the decision-making body of the IMI Joint Undertaking (IMI JU), met on March 3 to kick-off the work of the Innovative Medicines Initiative in its attempt to overcome bottlenecks in European pharmaceutical R&D and support biomedical research for the benefit of patients.
Formal approval of IMI
20-12-07
The Council of ministers of the European Union formally adopted its Regulation setting up the Innovative Medicines Initiative
Competitiveness Council 23-11-2007
23-11-07
Council reached "general approach" on four joint technology initiatives
2820th Council Meeting, Competitiveness Council
28-09-07
The Council reached a common understanding on main elements related to four proposals aimed at establishing Joint Technology Initiatives
The Innovative Medicines Initiative Launches New Website
03-11-06
Today a new interactive, state-of-the-art website to mobilise participation in the Innovative Medicines Initiative (IMI) across Europe was launched by the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The URL:
http://www.imi-europe.org.
Europe's Innovative Medicines Initiative Moves Forward
18-09-06
Today the second version of the Strategic Research Agenda of the Innovative Medicines Initiative (IMI) was published by the European Federation of Pharmaceutical Industries and Associations (EFPIA).
Genedata Joins EC and Industry Consortium Tasked with Improving Medicines
10-05-06
Genedata announces its partnership with Innovative Medicines for Europe (InnoMed), a joint Industry and European Commission collaboration to promote discovery and improve drug safety. The consortium of 14 pharmaceutical companies and 3 academic institutions will work with the Swiss-based bioinformatics company to understand toxic reactions to medicines.
|